Lung disease, T-cells and inflammation in common variable immunodeficiency disorders

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 6, 2013, Pages 514-522

  Gregersen, Stina ^a   Holm, Are M ^a   Fevang, Borre ^c,e   Ueland, Thor ^a,c,d   Sikkeland, Liv I B ^a   Aalokken, Trond M ^b   Mynarek, Georg ^b   Kongerud, Johny ^a   Aukrust, Pål ^a,c,e   Johansen, Bjorn ^a   Froland, Stig S ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Department of Radiology and Nuclear Medicine ^*  (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Section of Endocrinology   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bronchiectasis; Bronchoalveolar lavage; Chemokines; Hypogammaglobulinemia; Interstitial lung disease

Indexed keywords

CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHIECTASIS; CD4 CD8 RATIO; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FIBEROPTIC BRONCHOSCOPY; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; INTERSTITIAL LUNG DISEASE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG PARENCHYMA; LUNG VOLUME; MALE; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESIDUAL VOLUME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TOTAL LUNG CAPACITY; VITAL CAPACITY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD4-CD8 RATIO; CHEMOKINE CCL19; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84884230021     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.819523     Document Type: Article

References (40)

1. Quinti I , Soresina A , Spadaro G , Martino S , Donnanno S , Agostini C , Claudio P , Franco D , Maria PA , Borghese F , Guerra A , Rondelli R , Plebani A . Long-term follow-up and outcome of a large cohort of patients with common variable immunodefi ciency . J Clin Immunol 2007 ; 27 : 308-16 . (Pubitemid 46790816)
2. Cunningham-Rundles C , Bodian C . C ommon variable immunodefi ciency: clinical and immunological features of 248 patients . Clin Immunol 1999 ; 92 : 34-48 . (Pubitemid 29315984)
3. Busse PJ , Farzan S , Cunningham-Rundles C . P ulmonary complications of common variable immunodefi ciency . Ann Allergy Asthma Immunol 2007 ; 98 : 1-8 . (Pubitemid 46106152)
4. Thickett KM , Kumararatne DS , Banerjee A K , Dudley R , Stableforth DE . Common variable immune defi ciency: respiratory manifestations, pulmonary function and highresolution CT scan fi ndings . QJM 2002 ; 95 : 655-62 . (Pubitemid 35203633)
5. Chapel H, Lucas M , Lee M , Bjorkander J , Webster D , Grimbacher B , Fieschi C , Thon V , Abedi MR , Hammarstrom L . Common variable immunodefi ciency disorders: division into distinct clinical phenotypes . Blood 2008 ; 112 : 277-86 .
6. Gregersen S , Aalokken TM , Mynarek G , Fevang B , Holm AM , Ueland T , Aukrust P , Kongerud J , Johansen B , Froland SS . Development of pulmonary abnormalities in patients with common variable immunodefi ciency: associations with clinical and immunologic factors . Ann Allergy Asthma Immunol 2010 ; 104 : 503-10
7. , Lien E , Kristoffersen AK , Muller F , Haug CJ, Espevik T , Froland SS . Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodefi ciency-possible immunologic and clinical consequences . Blood 1996 ; 87 : 674-81 . (Pubitemid 26030323)
8. Aukrust P , Froland SS , Muller F . Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features . Clin Exp Immunol 1992 ; 89 : 211-6 .
9. Cambronero R , Sewell WA , North ME , Webster AD , Farrant J . Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodefi ciency . J Immunol 2000 ; 164 : 488-94 . (Pubitemid 30013025)
10. Yong PF , Thaventhiran JE, Grimbacher B. A rose is a rose is a rose , but CVID is not CVID Common Variable Immune Defi ciency (CVID) . What do we know in 2011? Adv Immunol 2011 ; 111 : 47-107 .
11. Wright J J, Wagner D K , Blaese R M , Hagengruber C , Waldmann TA , Fleisher TA . Characterization of common variable immunodefi ciency: identifi cation of a subset of patients with distinctive immunophenotypic and clinical features . Blood 1990 ; 76 : 2046-51 .
12. Holm AM , Sivertsen E A , Tunheim S H , Haug T , Bjerkeli V , Yndestad A , Aukrust P , Froland SS . Gene expression analysis of peripheral T cells in a subgroup of common variable immunodefi ciency shows predominance of CCR7(-) effector-memory T cells . Clin Exp Immunol 2004 ; 138 : 278-89 . (Pubitemid 39472445)
13. Baumert E , Wolff-Vorbeck G , Schlesier M , Peter H H . Immunophenotypical alterations in a subset of patients with common variable immunodefi ciency (CVID) . Clin Exp Immunol 1992 ; 90 : 25-30 .
14. Fevang B, Yndestad A , Damas JK, Halvorsen B, Holm AM , Beiske K , Aukrust P , Froland SS . Chemokines and common variable immunodefi ciency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation . Clin Exp Immunol 2009 ; 158 : 237-45 .
15. Ebert LM , Schaerli P , Moser B . Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues . Mol Immunol 2005 ; 42 : 799-809 . (Pubitemid 40489029)
16. Weninger W, Carlsen HS , Goodarzi M , Moazed F , Crowley MA , Baekkevold ES , Cavanagh LL , von Andrian UH . Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis . J Immunol 2003 ; 170 : 4638-48 . (Pubitemid 36519970)
17. Schmutz C, Hulme A , Burman A , Salmon M , Ashton B , Buckley C , Middleton J . Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 . Arthritis Res Ther 2005 ; 7 : R217-29 .
18. British Thoracic Society guidelines on diagnostic fl exible bronchoscopy . Thorax 2001 ; 56(Suppl. 1) : i1-21 .
19. Conley M E , Notarangelo L D , Etzioni A . D iagnostic criteria for primary immunodefi ciencies. Representing PAGID (Pan-American Group for Immunodefi ciency) and ESID (European Society for Immunodefi ciencies) . Clin Immunol 1999 ; 93 : 190-7 .
20. Miller MR , Hankinson J, Brusasco V , Burgos F , Casaburi R , Coates A , Crapo R , Enright P , van der Grinten CP , Gustafsson P , Jensen R , Johnson DC , MacIntyre N , McKay R , Navajas D , Pedersen OF , Pellegrino R , Viegi G , Wanger J . Standardisation of spirometry . Eur Respir J 2005 ; 26 : 319-38 . (Pubitemid 41079078)
21. Gregersen S , Aalokken TM , Mynarek G , Kongerud J, Aukrust P , Froland SS , Johansen B . High resolution computed tomography and pulmonary function in common variable immunodefi ciency . Respir Med 2009 ; 103 : 873-80 .
22. Tammeling G J , Cotes J E, Pedersen OF, Peslin R , Yernault JC . Lung volumes and forced ventilatory fLows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offi cial Statement of the European Respiratory Society. Eur Respir J Suppl 1993 ; 16 : 5-40 .
23. MacIntyre N , Crapo RO , Viegi G , Johnson DC, van der Grinten CP , Brusasco V , Burgos F , Casaburi R , Coates A , Enright P , Gustafsson P , Hankinson J , Jensen R , McKay R , Miller MR , Navajas D , Pedersen OF , Pellegrino R , Wanger J . Standardisation of the single-breath determination of carbon monoxide uptake in the lung . Eur Respir J 2005 ; 26 : 720-35 . (Pubitemid 41448672)
24. Hansen J B, Halvorsen DS , Haldorsen BC, Olsen R , Sjursen H , Kierulf P . Retention of phagocytic functions in cryopreserved human monocytes . J Leukoc Biol 1995 ; 57 : 235-41 .
25. Damas JK, Gullestad L, Ueland T , Solum NO , Simonsen S, Froland SS , Aukrust P . CXC-chemokines, anew group of cytokines in congestive heart failure-possible role of platelets and monocytes . Cardiovasc Res 2000 ; 45 : 428-36 . (Pubitemid 30069508)
26. Baughman R P . T echnical aspects of bronchoalveolar lavage: recommendations for a standard procedure . Semin Respir Crit Care Med 2007 ; 28 : 475-85 . (Pubitemid 350036958)
27. Haslam P L , Baughman R P . Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL . Eur Respir J 1999 ; 14 : 245-8 . (Pubitemid 29461283)
28. Aukrust P , Muller F , Froland S S . Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodefi ciency (CVI) are associated with chronic immune activation and low numbers of CD4- lymphocytes . Clin Immunol Immunopathol 1994 ; 70 : 217-24 . (Pubitemid 24086596)
29. Meyer KC . B ronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 2007 ; 28 : 546-60 .
30. Costabel U , Guzman J . Effect of smoking on bronchoalveolar lavage constituents . Eur Respir J 1992 ; 5 : 776-9 .
31. Semenzato G . I mmunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection . Eur Respir J 1991 ; 4 : 94-102 .
32. Cazzato S , Zompatori M , Baruzzi G , Schiattone M L , Burzi M , Rossi A , Ratta L , Terzuolo G , Falcone F , Poletti V . Bronchiolitis obliterans-organizing pneumonia: an Italian experience . Respir Med 2000 ; 94 : 702-8 . (Pubitemid 30458795)
33. Kilinc G , Kolsuk EA . The role of bronchoalveolar lavage in diffuse parenchymal lung diseases . Curr Opin Pulm Med 2005 ; 11 : 417-21 . (Pubitemid 41291086)
34. Chetta A , Marangio E, Olivieri D . P ulmonary function testing in interstitial lung diseases . Respiration 2004 ; 71 : 209-13 . (Pubitemid 38608336)
35. Kunkel EJ, Boisvert J, Murphy K, Vierra MA , Genovese MC , Wardlaw AJ , Greenberg HB , Hodge MR , Wu L , Butcher EC , Campbell JJ . Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infi ltrating lymphocytes . Am J Pathol 2002 ; 160 : 347-55 . (Pubitemid 34052295)
36. Schaerli P , Moser B . Chemokines: control of primary and memory T-cell traffic . Immunol Res 2005 ; 31 : 57-74 . (Pubitemid 40065425)
37. Damas JK, Landro L, Fevang B, Heggelund L, Tjonnfjord GE , Floisand Y , Halvorsen B , Froland SS , Aukrust P . Homeostatic chemokines CCL19 and CCL21 promote infl ammation in human immunodefi ciency virus-infected patients with ongoing viral replication . Clin Exp Immunol 2009 ; 157 : 400-7 .
38. Damas JK, Smith C, Oie E, Fevang B, Halvorsen B , Waehre T , Boullier A , Breland U , Yndestad A , Ovchinnikova O , Robertson AK , Sandberg WJ , Kjekshus J , Tasken K , Froland SS , Gullestad L , Hansson GK , Quehenberger O , Aukrust P . Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization . Arterioscler Thromb Vasc Biol 2007 ; 27 : 614-20 .
39. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group . Eur Respir J 1989 ; 2 : 561-85 .
40. Kainulainen L , Nikoskelainen J , Vuorinen T , Tevola K , Liippo K , Ruuskanen O . Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia . Am J Respir Crit Care Med 1999 ; 159 : 1199-204 (Pubitemid 29202556).